# US 6,726,934 B1 · Micro-particulate and nano-particulate polymeric delivery system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,726,934 B1
- Document ID: US6726934B1
- Status: Granted
- Kind: B1
- Application number: 09/169,459
- Filed: 1998-10-09
- Granted: 2004-04-27
- Earliest claimed: 1997-10-09
- Assignees: Vanderbilt University
- Inventors: Ales Prokop
- Web page: https://patentgrep.com/patent/US6726934B1

## CPC

- A61K 9/5115: {Inorganic compounds}
- A61K 9/5146: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides}
- A61K 9/5161: {Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin}
- A61K 9/5169: {Proteins, e.g. albumin, gelatin}
- A61K 9/5192: {Processes}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides a method of making particles useful in drug delivery, comprising the steps of: contacting polyanionic polymers with cations in a stirred reactor so that polyanions and the cations react to form particles.

## Claims

### Claim 1

A method of making nanoparticles comprised of a polyanionic/cationic complex, wherein said nanoparticles do not dissolve in physiological media for at least one day so as to be useful in drug delivery, said method comprising the steps of:
contacting at least two polyanionic polymers with at least two cations, wherein said contacting is by a process selected from the group consisting of capturing a mist of droplets comprising said polyanionic polymers in a liquid comprising said cations; and, capturing a mist of droplets comprising said cations in a liquid comprising said polyanionic polymers.

### Claim 2 (depends on 1)

The method of claim 1, wherein said polyanionic polymers are in a solution and said cations are in a solution.

### Claim 3 (depends on 1)

The method of claim 1, wherein said polyanionic polymers are provided in a solution, wherein said solution is dispersed as a cloud of droplets.

### Claim 4 (depends on 1)

The method of claim 1, wherein said method produces nanoparticles that have a polyanionic core and polyanionic/cationic complex shell (corona) with an excess positive charge on the particle periphery.

### Claim 5 (depends on 1)

The method of claim 1, wherein said cations are dispersed as a cloud of droplets and are collected in a polyanionic solution.

### Claim 6 (depends on 5)

The method of claim 5, wherein said method produces nanoparticles that have a cationic core and a cationic/polyanionic complex shell (corona) with the excess of negative charge on the particle periphery.

### Claim 7 (depends on 1)

The method of claim 1, wherein said polyanions and polycations are mixed together in the ratio of from about 1:1 to about 1:4.

### Claim 8 (depends on 4)

The method of claim 4, wherein individual components of the polyanionic polymers and cations are provided in solution at concentrations of 0.01 wt-% to 0.2 wt-%.

### Claim 9 (depends on 2)

The method of claim 2, wherein individual components of a cation solution are present at concentrations of 0.01 wt-% to 0.2 wt-%.

### Claim 10 (depends on 1)

The method of claim 1, wherein said polyanionic polymers further comprise an anionic antigen or protein, resulting in said antigen or protein being incorporated into the polyanionic/cationic complex formed upon contact of said polyanionic polymers with said cations.

### Claim 11 (depends on 1)

The method of claim 1, wherein a nonionic polymeric surface modifier is included in one or more components selected from the group consisting of said polyanionic polymers and said cations, so that said nonionic polymeric surface modifier is incorporated into said polyanionic/cationic complex as a steric stabilizer.

### Claim 12 (depends on 1)

The method of claim 1, wherein said cations further comprise a cationic antigen or protein, resulting in said antigen or protein being incorporated into the polyanionic/cationic complex formed upon contact of said cations with said polyanionic polymers.
